Abel Hall, LLC

Position in ABBV — AbbVie Inc.

CIK 2013339 BATON ROUGE, LA

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$1,856,599

+$1,130,835 QoQ

Shares Held

7,378

+121.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

#2,023

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Abel Hall, LLC holds $16,989,938 across 13 Drug Manufacturers - General names. ABBV ranks #4 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,675	$3,208,475
2	JNJ	Johnson & Johnson	9,158	$2,325,857
3	NVS	Novartis AG	14,598	$2,287,798
4	ABBV	AbbVie Inc. This page	7,378	$1,856,599
5	BMY	Bristol Myers Squibb Co	20,767	$1,196,594
6	MRK	Merck & Co., Inc.	7,789	$1,000,886
7	PFE	Pfizer Inc	40,621	$978,153
8	NVO	Novo Nordisk A S	19,198	$920,352

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,856,599	7,378	+121.1%	Shares	Sole	2026-07-24
2026-03-31	$725,764	3,337	+10.5%	Shares	Sole	2026-04-28
2025-12-31	$690,268	3,021	+4.5%	Shares	Sole	2026-02-17
2025-09-30	$669,613	2,892	+0.3%	Shares	Sole	2025-11-17
2025-06-30	$535,142	2,883	-2.7%	Shares	Sole	2025-07-23
2025-03-31	$621,017	2,964	+13.8%	Shares	Sole	2025-05-06
2024-12-31	$462,908	2,605	+7.0%	Shares	Sole	2025-01-23
2024-09-30	$480,666	2,434	+3.7%	Shares	Sole	2024-11-15
2024-06-30	$402,728	2,348	+7.0%	Shares	Sole	2024-07-25
2024-03-31	$399,709	2,195	-48.3%	Shares	Sole	2024-05-08
2023-12-31	$657,382	4,242	—	Shares	Sole	2024-02-28
No filing history on record for this holder in this stock.